Languages SpokenEnglish Prescribed MedicationsAlendronate Gammaplex (Generic Name: immun glob g(igg)/gly/iga 0-50) Taltz Autoinjector (Generic Name: ixekizumab) Skyrizi Pen (Generic Name: risankizumab-rzaa) Calcipotriene Research PublicationsApproximately 50% of Dermatologists in Saint Louis, MO have available research publications Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. Evangelos J Giamarellos-Bourboulis, Gregor B E Jemec, Errol P Prens, Niels C Riedemann, Isabell Otto, Jamie Weisman, Grazyna Pulka, Roman J Nowicki, Vessel Kantardjiev, Andreas Pinter, Simon Francis Thomsen, Debra Berneman, Theodora Kanni, Afsaneh Alavi, Brigitte Breno, Melinda Gooderham, Melody Stone, Milan J Anadkat, Alexandros Katoulis, Markos Papakonstantis, Pierre-André Becherel, Jacek C Szepietowski, Hessel H van der Zee, Christos C Zouboulis, Christopher J Sayed The British journal of dermatology 2026-01-27 Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares. James G Krueger, Mrinal K Sarkar, Mark G Lebwohl, Akimichi Morita, Kenneth Gordon, Rachael Bogle, Christopher Cole, Anthony Coon, Richard G Langley, Richard B Warren, Arash Mostaghimi, Bruce Strober, A David Burden, Min Zheng, Aaron R Mangold, Milan J Anadkat, Jonathan N Barker, Joseph F Merola, Lam C Tsoi, Ming Tang, Kolja Becker, Denis Delic, Christian Thoma, Johann E Gudjonsson The Journal of clinical investigation 2025-07-01 Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions. Kenneth B Gordon, Yayoi Tada, Milan J Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi Dermatology and therapy 2025-06 Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions. Kenneth B Gordon, Yayoi Tada, Milan J Anadkat, Siew Eng Choon, Boni Elewski, Jonathan N Barker, Arash Mostaghimi, Kilian Eyerich, Ming Tang, Thomas Haeufel, Christian Thoma, Diamant Thaçi Dermatology and therapy 2025-02-10 Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. Sonja Ständer, Gil Yosipovitch, Franz J Legat, Adam Reich, Carle Paul, Dagmar Simon, Luigi Naldi, Martin Metz, Athanasios Tsianakas, Andrew Pink, Simon Fage, Giuseppe Micali, Elke Weisshaar, Hema Sundaram, Andrei Metelitsa, Matthias Augustin, Andreas Wollenberg, Bernhard Homey, Maria Concetta Fargnoli, Howard Sofen, Neil J Korman, Lone Skov, Xiaoxiao Chen, Zarif K Jabbar-Lopez, Christophe Piketty, Shawn G Kwatra, OLYMPIA 1 Investigators JAMA dermatology 2025-02-01 Development of the Generalized Pustular Psoriasis Clinical Assessment Tool. Amit Garg, Megan H Noe, Milan J Anadkat, April Armstrong, Tina Bhutani, Aaron Farberg, George Han, Jason E Hawkes, Mark Lebwohl, Sergey Rekhtman, Eingun J Song, Andrew Strunk, Kristina C Duffin Journal of the American Academy of Dermatology 2023-09-20 Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. Akimichi Morita, Bruce Strober, A David Burden, Siew Eng Choon, Milan J Anadkat, Slaheddine Marrakchi, Tsen-Fang Tsai, Kenneth B Gordon, Diamant Thaçi, Min Zheng, Na Hu, Thomas Haeufel, Christian Thoma, Mark G Lebwohl Lancet (London, England) 2023-09-19 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Milan Anadkat, MD has received over $111,627 in payments from medical companies (3 times the average Dermatologist in Saint Louis, MO) - Over $84,158 in payments for Consulting Fee (7 times the average Dermatologist in Saint Louis, MO)
- Over $14,697 in payments for Compensation for services other than consulting, including serving as faculty or as a speaker at a v (18% less than the average Dermatologist in Saint Louis, MO)
- Over $8,600 in payments for Honoraria (15 times the average Dermatologist in Saint Louis, MO)
- Over $2,758 in payments for Travel and Lodging (8% less than the average Dermatologist in Saint Louis, MO)
- Over $1,397 in payments for Food and Beverage (59% less than the average Dermatologist in Saint Louis, MO)
- Over $15 in payments for Education (86% less than the average Dermatologist in Saint Louis, MO)
Boehringer Ingelheim International GmbH - $217.24 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 12/30/2024 Boehringer Ingelheim International GmbH - $6.79 payment for Compensation for services other than consulting, including serving as faculty or as a speaker at a v on 12/30/2024 Novartis Pharmaceuticals Corporation - $3,300.00 payment for Consulting Fee on 12/07/2024 Novartis Pharmaceuticals Corporation - $104.97 payment for Food and Beverage on 12/07/2024 Eli Lilly and Company - $2,200.00 payment for Consulting Fee on 12/03/2024 UCB, Inc. - $8,775.00 payment for Consulting Fee on 07/05/2024 Eli Lilly and Company - $6,000.00 payment for Consulting Fee on 06/27/2024 Eli Lilly and Company - $49.13 payment for Travel and Lodging on 06/18/2024 Eli Lilly and Company - $728.00 payment for Travel and Lodging on 06/18/2024 Eli Lilly and Company - $16.05 payment for Food and Beverage on 06/18/2024
Affiliated FacilitiesBarnes Jewish Hospital
|